Purdue University researchers have developed a new device called tumor-microenvironment-on-chip (T-MOC) , which promises to provide nanomedicine researchers with a stable platform to test techniques that involve nanoparticle therapy for tumors.
This new device has 3-dimensional microfluidic channels, which in turn consist of cancerous and endothelial cells. This environment is a replica of that which surrounds tumors in the human body.
Researchers can study if nanoparticles are able to reach the tumor cells by using this device. If the particles can get through the chip, it means that they can effectively target cancer cells.
The study details appear in the Journal of Controlled Release.